Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Howard

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Australasian Journal of Dermatology|July 7, 2020
Tildrakizumab in the treatment of moderate-to-severe hidradenitis suppurativaYonatan Kok, Jenny Nicolopoulos, Anne Howard, et al.
Bonekey Reports|July 14, 2016
Models of ex vivo explant cultures: applications in bone researchSilvia Marino, Katherine Ann Staines, Genevieve Brown, et al.
The Australasian Journal of Dermatology|July 18, 2002
Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitisSusanne Freeman, Anne Howard, Peter Foley, et al.
Radiologic Technology|September 14, 2017
GBCAs and Risk for Nephrogenic Systemic Fibrosis: A Literature ReviewAsher Street Beam, Kristi G Moore, Savannah N Gillis, et al.
Elife|December 7, 2018
Drought adaptation in <i>Arabidopsis thaliana</i> by extensive genetic loss-of-functionJ Grey Monroe, Tyler Powell, Nicholas Price, et al.
Research Square|December 3, 2025
First-in-line 3D-printed intravaginal ring for nonhormonal contraceptionSarah Anne Howard, Maimoona S Bhutta, Rima Janusziewicz, et al.
Drug Delivery and Translational Research|January 12, 2026
First-in-line 3D-printed intravaginal ring for nonhormonal contraceptionSarah Anne Howard, Maimoona S Bhutta, Rima Janusziewicz, et al.
Pharmaceutics|March 26, 2022
Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant PharmacokineticsJordan B Joiner, Jasmine L King, Roopali Shrivastava, et al.
Drug Delivery and Translational Research|May 27, 2025
First-in-line subcutaneous injectable for reversible, non-hormonal male contraceptionSarah Anne Howard, James K Tsuruta, Andres Prieto Trujillo, et al.
Nursing Reports (Pavia, Italy)|December 30, 2021
Practice What We Preach: Beginning a Journey to Embrace Patient-Centered Outcomes ResearchHuey-Ming Tzeng, Bridget E Hawkins, Anne Howard, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Australasian Journal of Dermatology|July 7, 2020
Tildrakizumab in the treatment of moderate-to-severe hidradenitis suppurativaYonatan Kok, Jenny Nicolopoulos, Anne Howard, et al.
Bonekey Reports|July 14, 2016
Models of ex vivo explant cultures: applications in bone researchSilvia Marino, Katherine Ann Staines, Genevieve Brown, et al.
The Australasian Journal of Dermatology|July 18, 2002
Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitisSusanne Freeman, Anne Howard, Peter Foley, et al.
Radiologic Technology|September 14, 2017
GBCAs and Risk for Nephrogenic Systemic Fibrosis: A Literature ReviewAsher Street Beam, Kristi G Moore, Savannah N Gillis, et al.
Elife|December 7, 2018
Drought adaptation in <i>Arabidopsis thaliana</i> by extensive genetic loss-of-functionJ Grey Monroe, Tyler Powell, Nicholas Price, et al.
Research Square|December 3, 2025
First-in-line 3D-printed intravaginal ring for nonhormonal contraceptionSarah Anne Howard, Maimoona S Bhutta, Rima Janusziewicz, et al.
Drug Delivery and Translational Research|January 12, 2026
First-in-line 3D-printed intravaginal ring for nonhormonal contraceptionSarah Anne Howard, Maimoona S Bhutta, Rima Janusziewicz, et al.
Pharmaceutics|March 26, 2022
Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant PharmacokineticsJordan B Joiner, Jasmine L King, Roopali Shrivastava, et al.
Drug Delivery and Translational Research|May 27, 2025
First-in-line subcutaneous injectable for reversible, non-hormonal male contraceptionSarah Anne Howard, James K Tsuruta, Andres Prieto Trujillo, et al.
Nursing Reports (Pavia, Italy)|December 30, 2021
Practice What We Preach: Beginning a Journey to Embrace Patient-Centered Outcomes ResearchHuey-Ming Tzeng, Bridget E Hawkins, Anne Howard, et al.
Pageof 4